Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows (Unaudited)

v3.21.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Cash Flows From Operating Activities    
Net loss $ (2,099,481) $ (874,336)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation 484 2,112
Non-cash lease expense for right-of-use assets 20,450 19,548
Amortization of debt issuance costs 1,070
Amortization of intangible asset 198,832 198,832
Deferred income tax benefit (89,248) (128,129)
Stock-based compensation 308,298 98,663
Net changes in operating assets and liabilities:    
Prepaid expenses and other (557,137) 129,353
Operating lease liability (20,949) (19,217)
Accrued interest 362 16,100
Accounts payable (143,673) 17,604
Due (from) to related parties 122,564 (28,312)
Other receivables 6,750
Accrued expenses 9,219 20,259
Net cash used in operating activities (2,243,529) (546,453)
Cash Flows From Financing Activities    
Net proceeds from private placement 9,875,550
Transaction costs related to fundraising efforts (2,806)
Net cash (used in) provided by financing activities 9,875,550 (2,806)
Net Increase (Decrease) in Cash 7,632,021 (549,259)
Cash and Cash Equivalents - Beginning of Period 15,416,224 691,536
Cash and Cash Equivalents - End of Period $ 23,048,245 $ 142,277